Armistice Capital »

Crispr Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $27M 600k 45.39
2023-06-30 $28M 500k 56.14
2023-03-31 $37M 824k 45.23
2022-12-31 $42M 1.0M 40.65
2022-09-30 $60M 924k 65.35
2022-03-31 $64M 1.0M 62.77
2021-12-31 $68M 892k 75.78
2021-09-30 $43M 380k 111.93
2021-06-30 $26M 158k 161.89
2021-03-31 $19M 156k 121.85
2020-12-31 $11M 72k 153.11
2020-09-30 $17M 204k 83.64
2020-06-30 $14M 188k 73.49
2020-03-31 $10M 236k 42.41
2019-12-31 $9.0M 148k 60.91
2019-09-30 $11M 264k 40.99
2019-03-31 $2.9M 80k 35.72
2018-12-31 $4.9M 172k 28.57
2018-06-30 $7.3M 124k 58.76